Literature DB >> 2565004

Raised serum lipoprotein during treatment with lovastatin.

G Jürgens, A Ashy, G Zenker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2565004     DOI： 10.1016/s0140-6736(89)92921-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Changes in Lp(a) lipoprotein levels during the treatment of hypercholesterolaemia with simvastatin.

Authors:  L Slunga; O Johnson; G H Dahlén
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  HMG-CoA reductase inhibitor use in the aged. A review of clinical experience.

Authors:  C J Lintott; R S Scott
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

3.  Proceedings of the British Pharmacological Society. 12-14 September 1990, Belfast.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

4.  Simvastatin in severe hypercholesterolaemia: a placebo controlled trial.

Authors:  I F McDowell; M Smye; T Trinick; J A Shortt; M P Archibald; E R Trimble; D P Nicholls
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

5.  Long-term effect of lovastatin alone and in combination with cholestyramine on lipoprotein (a) level in familial hypercholesterolemic subjects.

Authors:  T P Leren; I Hjermann; O P Foss; P Leren; K Berg
Journal:  Clin Investig       Date:  1992-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.